Related Experiment Video
Updated: Aug 9, 2025
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Currently available therapies in mitochondrial disease
Cornelia Kornblum1, Costanza Lamperti2, Sumit Parikh3
1Department of Neurology, Neuromuscular Disease Section, University Hospital Bonn, Bonn, Germany.
Abstract:
Mitochondrial diseases are a heterogeneous group of multisystem disorders caused by impaired mitochondrial function. These disorders occur at any age and involve any tissue, typically affecting organs highly dependent on aerobic metabolism. Diagnosis and management are extremely difficult due to various underlying genetic defects and a wide range of clinical symptoms. Preventive care and active surveillance are strategies to try to reduce morbidity and mortality by timely treatment of organ-specific complications. More specific interventional therapies are in early phases of development and no effective treatment or cure currently exists. A variety of dietary supplements have been utilized based on biological logic. For several reasons, few randomized controlled trials have been completed to assess the efficacy of these supplements. The majority of the literature on supplement efficacy represents case reports, retrospective analyses and open-label studies. We briefly review selected supplements that have some degree of clinical research support. In mitochondrial diseases, potential triggers of metabolic decompensation or medications that are potentially toxic to mitochondrial function should be avoided. We shortly summarize current recommendations on safe medication in mitochondrial diseases. Finally, we focus on the frequent and debilitating symptoms of exercise intolerance and fatigue and their management including physical training strategies.
Insights
Mitochondrial diseases are complex genetic disorders affecting multiple organs. Current management focuses on supportive care, supplements, and avoiding toxic medications, as effective treatments are limited.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Mitochondrial diseases are a diverse group of inherited disorders impacting cellular energy production.
- These conditions affect any organ system, particularly those with high aerobic metabolism, leading to significant morbidity.
- Diagnosis and management are challenging due to genetic heterogeneity and varied clinical presentations.
Approach:
- Reviewing current literature on dietary supplements with some clinical research support for mitochondrial disorders.
- Summarizing recommendations for safe medication use in patients with mitochondrial diseases.
- Discussing management strategies for exercise intolerance and fatigue, including physical training.
Key Points:
- No definitive cure or effective treatment currently exists for most mitochondrial diseases.
- Dietary supplements are commonly used, but robust evidence from randomized controlled trials is scarce.
- Avoiding metabolic decompensation triggers and potentially toxic medications is crucial for patient care.
- Exercise intolerance and fatigue are common debilitating symptoms requiring specific management approaches.
Conclusions:
- Current management of mitochondrial diseases relies on supportive care, symptom management, and preventive strategies.
- Further research is needed to develop specific interventional therapies and validate supplement efficacy.
- Personalized approaches considering genetic defects and clinical manifestations are essential for optimal patient outcomes.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
01:48ATP Synthase: Mechanism
01:45Mitochondrial Membranes
02:59Animal Mitochondrial Genetics